Back to Exchange Traded Concepts, LLC Exchange Traded Concepts, LLC

JANX

9 quarters

Position history for Exchange Traded Concepts, LLCExchange Traded Concepts, LLC's holdings in Janux Therapeutics, Inc.

No. Exchange Traded Concepts exited its JANX (Janux Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 4,043 shares worth $109,161. Exchange Traded Concepts first reported JANX in Q2 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$118,819

Total Shares Change

-10,010

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$23.10
0
2025-Q1
Increased
4,043
+20.4%
$109,1610.0%$27.00
26
2024-Q4
Unchanged
3,357
0.0%
$179,7340.0%$53.54
0
2024-Q3
Decreased
3,357
-41.7%
$152,5090.0%$46.25
0
2024-Q2
Decreased
5,754
-23.7%
$241,0350.0%$41.89
0
2024-Q1
Decreased
7,544
-46.9%
$284,0320.0%$37.65
0
2023-Q4
Increased
14,204
+34.0%
$152,4090.0%$10.73
29
2023-Q3
Increased
10,602
+5.9%
$106,8680.0%$10.08
23
2023-Q2
New
10,010
-
$118,8190.0%$11.53
30

Other major holders of JANX: RA Capital Management, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used